A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
A data-minimizing way to research health data is Secure Multiparty Computation. On the successful implementation of the ...
It’s widely known that artificial intelligence (AI) is profoundly reshaping the healthcare industry. Hospitals have used AI in a variety of ways, from streamlining workflows to aiding in bedside ...
A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in ...
Clinical data archiving, the movement of inactive patient information from a production electronic health record (EHR) to a long-term storage solution, has been happening at major hospitals and health ...
When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...
A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results